Back
Speaker illustration

Doctor Rey Adam Cordovez

Vicente Sotto Memorial Medical Center, Cebu City (Philippines)

Member of:

European Society of Cardiology

He earned his medical degree at the Mindanao State University - College of Medicine as a university scholar last 2006. Had his residency training in Internal Medicine at Vicente Sotto Memorial Medical Center. And his fellowship training in Adult Cardiology at the Philippine Heart Center.

Presentations Articles

Cardiovascular outcomes of sodium glucose co-transporter-2 inhibitor treatment in cancer patients receiving anthracycline chemotherapy: a systematic review and meta-analysis

Event: ESC Congress 2025

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Session: Cardio-oncology: around the world

Access
Like
Thumbnail

Effects of sodium-glucose co-transporter-2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Heart failure therapy across the spectrum

Access
Like
Thumbnail

Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis

Event: ESC Asia 2022 with APSC & AFC

Topic: Cardiovascular Pharmacotherapy

Session: Pharmacology and Pharmacotherapy

Access
Like
Thumbnail

Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Chronic heart failure treatment

Access
Like
Thumbnail

Efficacy of sodium glucose cotransporter-2 inhibitors for heart failure with preserved and with mildly reduced ejection fraction: a systematic review and meta-analysis

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 3

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources